InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,702.55
(
-0.19%
)
US TECH 100
19,282.72
(
-0.27%
)
Dow Jones
42,063.36
(
0.09%
)
Brent Oil
74.14
(
0.00%
)
Bitcoin
62,925.44
(
-0.44%
)
Post# of 253168
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 840
Posts 120475
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 212825

Wednesday, 11/01/2017 9:22:53 AM

Wednesday, November 01, 2017 9:22:53 AM

Post# of 253168
3Q17 worldwide Botox sales=$775M, +12% YoY (-5% QoQ*):

http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyNjM5NjJ8Q2hpbGRJRD02ODMxNjA=

• US therapeutic: $368.9M (+15% YoY)
• US cosmetic: $189.7M (+8% YoY)
• Ex-US therapeutic: $84.4M (+5% YoY in local currency)
• Ex-US cosmetic: $131.5M (+15% YoY in local currency)

All told, 72% of Botox sales were in the US, where the therapeutic/cosmetic split was 66/34; 28% of Botox sales were ex-US, where the therapeutic/cosmetic split was 39/61.

*The 3Q17 sales decline vs 2Q17 was expected; for cosmetic indications, the second and fourth quarters are seasonally stronger than the first and third quarters.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up